Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2

CELL RESEARCH

SPRINGERNATURE

1. National Science & Technology Major Project Key New Drug Creation and Manufacturing Program of China [2018ZX09711002]
2. National Key R&D Program of China [2018YFA0507002]
3. Shanghai Municipal Science and Technology Major Project [2019SHZDZX02]
4. Strategic Priority Research Program of Chinese Academy of Sciences [XDB37030103]
5. Youth Innovation Promotion Association of Chinese Academy of Sciences [2018367, 2021278]
6. Shanghai Science and Technology Committee [21S11903100]
7. National Natural Science Foundation of China [31970165]
8. 2020 ANSO Collaborative Research Project [ANSO-CR-SP-2020-03]